JPRN-jRCT2031260281 clinical trial report covering Oremepermin alfa, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

JPRN-jRCT2061260037 clinical trial report covering Umedaptanib pegol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600127737 clinical trial report covering Topiramate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600127720 clinical trial report covering Serplulimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07684820 clinical trial report covering XH-S004, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07684326 clinical trial report covering Dapagliflozin, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.

NCT07685704 clinical trial report covering Tislelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07685938 clinical trial report covering Lisinopril, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07682961 clinical trial report covering Zinlirvimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07683000 clinical trial report covering Zinlirvimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262444 clinical trial report covering Fuzheng Tonglin Pills, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07684144 clinical trial report covering Maridebart Cafraglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.